SCHEMBL20252174

SCHEMBL20252174

OBOc1ccc(-n2c3ccccc3c3ccccc32)cc1F

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ ATM Q13315 1/20 0.41
▸ MAPK1 P28482 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ PTPN1 P18031 2/20 0.33
▸ USP14 P54578 1/20 0.33
▸ F2 P00734 1/20 0.33
▸ F10 P00742 1/20 0.33
▸ PRSS1 P07477 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.32
▸ HTT P42858 1/20 0.32
▸ POLB P06746 1/20 0.31
▸ TRPA1 O75762 1/20 0.31
▸ HDAC4 P56524 1/20 0.30
▸ MET P08581 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ RECQL P46063 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20252170 0.91 L3MBTL1 (0.41) L3MBTL1KDM4EATMMAPK1SMN1; SMN2
SCHEMBL14648914 0.81 SMN1; SMN2 (0.44) L3MBTL1KDM4EATMMAPK1SMN1; SMN2
SCHEMBL11978644 0.75 KDM4E (0.50) L3MBTL1KDM4EATMSMN1; SMN2PTPN1
SCHEMBL14648922 0.75 ALDH1A1 (0.41) L3MBTL1KDM4EATMALDH1A1HTT
SCHEMBL15887992 0.74 KDM4E (0.48) L3MBTL1KDM4EATMSMN1; SMN2PTPN1
SCHEMBL10066241 0.74 KDM4E (0.53) L3MBTL1KDM4EATMSMN1; SMN2PTPN1
SCHEMBL19564386 0.74 F2 (0.41) L3MBTL1KDM4EATMPTPN1F2
SCHEMBL12754467 0.74 KDM4E (0.52) L3MBTL1KDM4EATMMAPK1SMN1; SMN2
SCHEMBL16500778 0.73 KDM4E (0.47) L3MBTL1KDM4EATMSMN1; SMN2PTPN1
SCHEMBL19169128 0.71 ALDH1A1 (0.46) L3MBTL1KDM4EATMSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180166634-A1 ORGANIC LIGHT-EMITTING DEVICE AND COMPOUND SAMSUNG ELECTRONICS CO LTD (KR) 2018-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180166634-A1 ORGANIC LIGHT-EMITTING DEVICE AND COMPOUND L1CAM, OR10J3, EML4 L3MBTL1 100/4885KDM4E 1971/4885ATM 3868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback